Six months of retrospective glycemic control and anthropometric outcomes in type 2 diabetic patients with new dapagliflozin treatment actual clinical experience data from single center.

20th European Congress of Endocrinology. Barcelona, Spain., 19 - 22 Mayıs 2018, (Tam Metin Bildiri)